Browsing Category
Healthcare Industry News
2513 posts
Is Fulgent Genetics rebuilding itself as a pathology-first diagnostics platform after losing a major customer?
Fulgent Genetics targets $350M 2026 revenue as pathology expansion reshapes its customer mix. Read how the strategy could stabilise growth.
Haleon plc (LON: HLN) FY2025 results: Can margin expansion, operating model reform, and capital discipline overcome weak North American demand?
Haleon plc posts 3% organic growth and 10.5% profit expansion in FY2025. Can margin gains and buybacks drive stronger returns in 2026? Read more.
Gallant and MWI Animal Health are building the infrastructure veterinary regenerative medicine never had
Gallant and MWI Animal Health create veterinary medicine's first ultra-cold chain ahead of a potential FDA first. Read the full executive analysis.
How FDA-aligned endpoints position inFoods IBS alongside drug therapies
Biomerica, Inc. aligns inFoods IBS with FDA drug endpoints and secures Medicare pricing. See what this means for IBS competitors and investors.
Is AI-enabled longevity testing ready for clinical adoption? 20/20 BioLabs Inc. tests the market
Is AI-enabled longevity testing ready for clinical adoption? Explore how 20/20 BioLabs Inc. is using IBM AI to reshape preventive diagnostics.
Sai Life Sciences (NSE: SAILIFE) accelerates talent expansion to support complex drug development demand
Sai Life Sciences Limited plans 700+ hires in FY27 as it scales R&D and manufacturing. Find out what this expansion signals for India’s CRDMO sector.
How Lumee Oxygen could influence intraoperative decision-making in limb ischemia
Profusa, Inc. raises guidance as Lumee Oxygen gains traction in Europe. Discover how real-time oxygen data could reshape limb ischemia surgery.
Why WestFax is betting that healthcare automation starts with fax, not EHR replacement
Discover how WestFax Comprehend uses AI to automate healthcare document intake while preserving existing workflows and compliance. Read the full analysis.
Why Science Corporation’s ecosystem deal with Neurosoft Bioelectronics could reshape how brain interfaces scale
Science Corporation’s BCI ecosystem deal with Neurosoft Bioelectronics hints at a platform shift in brain-computer interfaces. Read why this matters now.
Exact Sciences stockholders approve Abbott acquisition, clearing final hurdle in $21bn cancer diagnostics deal
Exact Sciences stockholders approve Abbott’s $21 billion acquisition. Find out how the deal could reshape cancer diagnostics and investor strategy.